Skip to main content

tirbanibulin (Klisyri®)

 

Following a full submission

AWMSG advice

Status: Recommended

Tirbanibulin (Klisyri®) is recommended as an option for use within NHS Wales for the field treatment of non hyperkeratotic, non hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp in adults.

 Final Recommendation: tirbanibulin (Klisyri) 4076 (PDF, 379Kb)
 Appraisal Report: tirbanibulin (Klisyri) 4076 (PDF, 412Kb)

Medicine details

Medicine name tirbanibulin (Klisyri®)
Formulation 10 mg/g ointment
Reference number 4076
Indication

For the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp in adults

Company Almirall Ltd
BNF chapter Skin
Submission type Full
Status Recommended
Advice number 0122
NMG meeting date 05/01/2022
AWMSG meeting date 09/02/2022
Date of issue 23/02/2022
Follow AWTTC: